Response vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
US YC W20 indirect procurement for operations teams with 13.2% cost savings and 91.6% time reduction; $4M Twenty-Two Ventures/YC seed with Flexport/Anduril/Ramp angels serving Aterian competing with Coupa for indirect spend control.
About
Response is a United States-based indirect procurement platform — backed by Y Combinator (W20) with $4 million in seed funding led by Twenty-Two Ventures with angels from Flexport, Anduril, Ramp, and Scale AI — providing operations teams with end-to-end control over indirect spend (office supplies, maintenance materials, packaging, facilities consumables) by streamlining ordering workflows, enforcing approval processes, and enabling vendor consolidation. Helping customers including Aterian (NASDAQ: ATER) and Warehouse Specialists Inc. achieve up to 13.2% cost savings and 91.6% ordering time reduction. Founded in 2019 by Keivan Shahida and Kais Baillargeon, Response addresses the unmanaged spend problem that creates significant cost leakage for industrial and operations-intensive businesses.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.